Hengrui Pharma at ESMO 2026: Innovations in Oncology
Pushing Boundaries at ESMO 2026 If there's one place where the future of cancer treatment is being etched out, it's at forums like the ESMO Congress. This year, Hengrui Pharma is rolling in with 64 research findings hotter than a two-dollar pistol, all set to make waves in oncology. From breast to lung cancer, they're covering the lot and showcasing a blend of established...
Continue Reading